BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Aspirin
,
rs7903146
,
PRKCA
,
Apoptosis
,
Influenza
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hizentra
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated w…
Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients wi…
Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates…
Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary…
Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodef…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Efficacy and Tolerability of Hizentra®
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on…
Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ